Valuation Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 15/12/2025 pm IST			5-day change	1st Jan Change
316.40 ^DKK	-1.48%		+2.20%	-49.31%

15/12	US FDA grants priority voucher to J&J's blood cancer treatment	RE
15/12	Eli Lilly Could Get FDA Decision for Weight-Loss Pill Orforglipron by March 2026	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	9,86,612	16,74,992	21,18,803	31,12,331	27,72,285	14,05,917	-	-
Change	-	69.77%	26.5%	46.89%	-10.93%	-49.29%	-	-
Enterprise Value (EV) ¹	9,84,211	16,84,152	21,21,013	31,09,107	28,48,764	15,10,203	15,05,509	14,88,893
Change	-	71.12%	25.94%	46.59%	-8.37%	-46.99%	-0.31%	-1.1%
P/E ratio	23.7x	35.4x	38.4x	37.5x	27.6x	13.7x	13.8x	12.8x
PBR	15.8x	24x	25.6x	29.4x	19.3x	7.45x	6.2x	5.34x
PEG	-	2.3x	2.2x	0.7x	1.3x	7.23x	-22.41x	1.63x
Capitalization / Revenue	7.77x	11.9x	12x	13.4x	9.55x	4.57x	4.6x	4.29x
EV / Revenue	7.75x	12x	12x	13.4x	9.81x	4.91x	4.93x	4.54x
EV / EBITDA	16.4x	26x	25.8x	27.8x	19.3x	10.2x	10.3x	9.36x
EV / EBIT	18.2x	28.7x	28.4x	30.3x	22.2x	11.7x	11.8x	10.8x
EV / FCF	34.5x	57.4x	37x	45.5x	38.6x	30x	21.9x	17x
FCF Yield	2.9%	1.74%	2.7%	2.2%	2.59%	3.33%	4.57%	5.89%
Dividend per Share ²	4.55	5.2	6.2	9.4	11.4	11.63	11.41	12.13
Rate of return	2.13%	1.41%	1.32%	1.35%	1.83%	3.68%	3.61%	3.83%
EPS ²	9.005	10.37	12.22	18.62	22.63	23.06	22.92	24.71
Distribution rate	50.5%	50.1%	50.7%	50.5%	50.4%	50.4%	49.8%	49.1%
Net sales ¹	1,26,946	1,40,800	1,76,954	2,32,261	2,90,403	3,07,594	3,05,468	3,28,079
EBITDA ¹	59,879	64,669	82,171	1,11,987	1,47,446	1,48,572	1,46,749	1,58,985
EBIT ¹	54,126	58,644	74,809	1,02,574	1,28,339	1,28,529	1,27,756	1,37,989
Net income ¹	42,138	47,757	55,525	83,683	1,00,988	1,02,716	99,650	1,07,064
Net Debt ¹	-2,401	9,160	2,210	-3,224	76,479	1,04,286	99,593	82,976
Reference price ²	213.32	367.50	469.00	698.10	624.20	316.40	316.40	316.40
Nbr of stocks (in thousands)	46,24,923	45,57,801	45,17,704	44,58,288	44,41,340	44,43,479	-	-
Announcement Date	03/02/21	02/02/22	01/02/23	31/01/24	05/02/25	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVO NORDISK A/S	13.93x	4.98x	10.31x	3.62%	22TCr
ELI LILLY AND COMPANY	44.92x	14.86x	32.99x	0.58%	92TCr
JOHNSON & JOHNSON	20.19x	5.61x	15.54x	2.44%	51TCr
ABBVIE INC.	51.11x	7.4x	17.52x	2.92%	39TCr
ROCHE HOLDING AG	18.38x	4.62x	11.57x	3.12%	34TCr
ASTRAZENECA PLC	27.04x	5.12x	15.2x	1.8%	28TCr
NOVARTIS AG	18.3x	4.95x	11.64x	3.08%	25TCr
MERCK & CO., INC.	12.96x	4.23x	9.08x	3.22%	25TCr
AMGEN INC.	25.04x	5.94x	10.2x	3.01%	17TCr
GILEAD SCIENCES, INC.	17.56x	5.55x	10.14x	2.75%	15TCr
Average	24.94x	6.32x	14.42x	2.65%	34.91TCr
Weighted average by Cap.	29.64x	7.94x	18.37x	2.24%